CAS No.:72956-09-3
Name: Carvedilol
Details Introduction
TOXICITY DATA with REFERENCE:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | oral | > 1gm/kg (1000mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 20, Pg. 1181, 1989. |
mouse | LD50 | intraperitoneal | 364mg/kg (364mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA |
New Cardiovascular Drugs. Vol. 5, Pg. 135, 1987. |
mouse | LD50 | intravenous | 27mg/kg (27mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LIVER: OTHER CHANGES |
New Cardiovascular Drugs. Vol. 5, Pg. 135, 1987. |
mouse | LDLo | oral | 8gm/kg (8000mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 20, Pg. 1181, 1989. |
rat | LD50 | intraperitoneal | 769mg/kg (769mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA |
New Cardiovascular Drugs. Vol. 5, Pg. 135, 1987. |
rat | LD50 | intravenous | 25mg/kg (25mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LIVER: OTHER CHANGES |
New Cardiovascular Drugs. Vol. 5, Pg. 135, 1987. |
rat | LDLo | oral | 8gm/kg (8000mg/kg) | GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 20, Pg. 1181, 1989. |
Consensus Reports:
SAFETY PROFILE:
Hazard Codes of Carvedilol (CAS NO.72956-09-3): N,
Xn
Risk Statements: 51/53-36/37/38-20/21/22
R51/53: Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
R36/37/38: Irritating to eyes, respiratory system and skin.
R20/21/22: Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 61-36-26
S61: Avoid release to the environment. Refer to special instructions / safety data sheets.
S36: Wear suitable protective clothing.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
RIDADR: UN 3077 9/PG 3
RTECS: UA8670000
Standards and Recommendations:
Analytical Methods:
Related Searches

Related Suppliers
- HANWAYS CHEMPHARM CO.,LIMITED
- Sinoway Industrial Co., Ltd.
- Dayang Chem (Hangzhou) Co.,Ltd.
- Afine Chemicals Limited
- Cartoon Ingredients Co., Ltd
- SHUNYUANSHENG BIO-PHARMTECH CO., LTD
- Wuhan Fortuna Chemical Co.,Ltd
- LIDE PHARMACEUTICALS LIMITED
- Xiamen Hisunny Chemical Co.,Ltd
- BOC Sciences
- Jai Radhe Sales
- Doctor Lifeline Remedies India Ltd
- Shanghai Haoyuan Chemexpress Co., Ltd.
- Nanjing Clasien Pharmaceutical&Chemical Co.,ltd
- Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
- Duke Chem S.A
- Gomti Life Sciences India Pvt Ltd
- Nanjing Legend Pharmaceutical & Chemical Co., Ltd.
- Shaanxi King Stone Enterprise Company Limited
- CIRON INC.
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione